Cardiovascular Devices Market is estimated to be valued at USD 71,240.80 Mn in 2026 and is expected to reach USD 1,42,666.1 Mn in 2033, exhibiting a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.
The growing global burden of heart and vascular diseases, along with an aging population, actively drives the cardiovascular devices market by increasing demand for accurate diagnosis and effective treatment solutions. Ongoing advances in medical technology enable the development of minimally invasive, implantable, and digitally enabled devices that enhance patient outcomes and speed recovery. Expanding healthcare infrastructure, rising awareness of cardiovascular health, and broader access to advanced cardiac care further strengthen market growth worldwide.
|
Current Events |
Description and its impact |
|
Regulatory and Policy Developments |
|
|
Technological Innovations and Advancements |
|
|
Economic and Healthcare Infrastructure Trends |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Therapeutic and Surgical Devices hold the largest market share of 87.5% in 2026. The need for timely intervention in complex heart conditions and the growing preference for procedure-based treatments over long-term medication actively drive therapeutic and surgical devices in the cardiovascular devices market. Ongoing improvements in device design, precision, and safety expand clinical adoption. Healthcare providers increasingly adopt minimally invasive and hybrid surgical procedures, while higher procedure volumes in specialized cardiac centers strengthen demand. Moreover, better clinical outcomes and reduced hospital stays motivate providers to use advanced therapeutic and surgical solutions. In November 2025, The Medicity announced the launch of its Advanced Surgical Heart Failure Clinic, a dedicated centre for diagnosing, surgically treating, and rehabilitating patients with complex and end-stage heart failure.
To learn more about this report, Download Free Sample
North America dominates the overall market with an estimated share of 47.9% in 2026. Advanced technology adoption and a growing focus on minimally invasive and outpatient cardiac procedures actively shape the North America cardiovascular devices market. Healthcare providers increasingly rely on implantable and catheter-based devices enhanced by digital monitoring and integrated data systems. The region continues to expand the use of personalized and precision-based cardiac therapies through early diagnosis and strong clinical expertise. Ongoing product innovation, established cardiac care infrastructure, and a focus on procedural efficiency further define current market trends.
In September 2025, GE HealthCare launched the Vivid Pioneer, a cardiovascular ultrasound system that uses AI to improve imaging speed and quality.
Healthcare systems across Europe increasingly prioritize preventive cardiology, early diagnosis, and long-term disease management, driving trends in the cardiovascular devices market. Providers actively adopt cost-effective, high-quality devices to manage the rising number of cardiovascular cases. Clinicians continue to expand the use of minimally invasive and transcatheter procedures, supported by strong expertise and structured care pathways. Moreover, strict regulatory standards, public healthcare coverage, and cross-border research collaborations actively shape product development and device adoption across the region.
In April 2024, Guy’s and St Thomas’ and King’s College London unveiled a HealthTech Research Centre at St Thomas’ Hospital to develop new technologies, medical devices, and digital solutions for cardiovascular and respiratory medicine.
Hospitals and specialized cardiac centers in the United States actively adopt innovative technologies and advanced procedural solutions, driving trends in the cardiovascular devices market. Clinicians increasingly use minimally invasive, implantable, and digitally connected devices to improve patient care and streamline interventions. Early detection, personalized treatment plans, and the integration of remote monitoring tools guide clinical decisions. Additionally, strong healthcare infrastructure, supportive reimbursement policies, and ongoing collaboration between medical device companies and research institutions actively promote the adoption of next-generation cardiovascular solutions. For instance, in June 2025, Cardinal Health has launched a single-patient monitoring cable and lead wire system in the U.S. that continuously tracks cardiac activity, blood oxygen, and temperature through one connection.
Hospitals and cardiac centers in the United Kingdom actively focus on preventive care and early intervention for heart diseases, driving trends in the cardiovascular devices market. Clinicians increasingly use minimally invasive and innovative therapeutic devices to enhance patient outcomes and shorten hospital stays. The integration of digital health solutions and remote monitoring enables continuous patient management. Moreover, strong public healthcare policies, government research support, and collaboration between clinical institutions and device manufacturers actively promote the development, adoption, and accessibility of advanced cardiovascular technologies across the region
The growing preference for minimally invasive procedures opens opportunities for innovative device development. Devices designed for catheter-based interventions, transcatheter valve replacements, and percutaneous therapies are increasingly in demand. Companies can focus on improving device precision, reducing procedural complexity, and integrating imaging guidance to expand clinical adoption and improve patient outcomes, creating a market niche for less invasive, safer, and more efficient cardiac treatments.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 71,240.80 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.9% | 2033 Value Projection: | USD 1,42,666.1 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Livanova PLC, B. Braun Melsungen AG, Edwards Lifesciences, Biotronik, Medtronic PLC, GE Healthcare, Cardinal Health Inc., Abbott Laboratories, Siemens Healthineers AG, WL Gore & Associates Inc., Boston Scientific Corporation, and Canon Medical Systems Corporation. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Share
Share
About Author
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
